British Health: Two doses of the AstraZeneca vaccine are 90% effective to stop Corona symptoms

Official estimates of the British Public Health Authority revealed that two doses of the Corona AstraZeneca vaccine are effective up to 90% in stopping the symptoms of the disease, as a public health analysis found that the British-made vaccine was as effective as a double dose of the Pfizer vaccine, according to a report by the British newspaper "Daily Mail" .

According to the report, the vaccination expert at the British Health Authority, Nadim Al-Zahawi, confirmed that these data highlight the great importance of obtaining two doses of the vaccine, and added: "There is no better weapon to push this virus than to obtain vaccines, as they are life-saving."

The second dose is vital to ensuring that we get the strongest protection possible so that we can return to normal life and get back to the things we love.

Dr Michael Head, Senior Research Fellow in Global Health at the University of Southampton, said, "It is reassuring to see the data from the Pfizer and Oxford AstraZeneca vaccines, that they are basically comparable in terms of efficacy against symptomatic disease, which is very high after two doses."

This came at a time when the British medical regulator approved plans to allow the Pfizer vaccine to be stored in the regular fridge for 31 days before it was administered, and Dr. John Ryan, head of the Medicines and Healthcare products Regulatory Agency (MHRA), said it would give patients greater access to the lifesaving vaccine. for life.

The British Minister of Health and Social Care Matt Hancock confirmed: "These new data show that the vaccine saves lives and protects you from ending up in the hospital with the Corona virus."

Last Tuesday, British research revealed that more than 90% of Britons develop antibodies to the Corona virus after being vaccinated with a single dose of the Pfizer or AstraZeneca vaccines.

The study conducted by University College London, according to what was reported by the British newspaper "The Guardian", that nearly 100% of those who were vaccinated had developed antibodies after the second dose of either of the two vaccines, as that study included 8 thousand and 517 people in England and Wales.